Epigenomics AG (EPGNF)
1.12
0.00 (0.00%)
USD |
OTCM |
Oct 09, 16:00
Epigenomics Net Income (Quarterly)
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -2.866M |
| March 31, 2023 | -5.999M |
| December 31, 2022 | -6.636M |
| September 30, 2022 | -1.570M |
| June 30, 2022 | -1.385M |
| March 31, 2022 | -2.981M |
| December 31, 2021 | -1.985M |
| September 30, 2021 | 3.343M |
| June 30, 2021 | -2.806M |
| March 31, 2021 | -1.447M |
| December 31, 2020 | -3.072M |
| September 30, 2020 | -3.219M |
| June 30, 2020 | -3.715M |
| March 31, 2020 | -3.285M |
| December 31, 2019 | -7.761M |
| September 30, 2019 | -2.884M |
| June 30, 2019 | -4.942M |
| March 31, 2019 | -3.427M |
| December 31, 2018 | -4.502M |
| September 30, 2018 | -3.459M |
| June 30, 2018 | -3.042M |
| March 31, 2018 | -3.957M |
| December 31, 2017 | -3.087M |
| September 30, 2017 | -1.338M |
| June 30, 2017 | -4.519M |
| Date | Value |
|---|---|
| March 31, 2017 | -2.526M |
| December 31, 2016 | -1.299M |
| September 30, 2016 | -2.609M |
| June 30, 2016 | -3.720M |
| March 31, 2016 | -4.768M |
| December 31, 2015 | -1.042M |
| September 30, 2015 | -2.680M |
| June 30, 2015 | -2.720M |
| March 31, 2015 | -3.557M |
| December 31, 2014 | -3.682M |
| September 30, 2014 | -2.440M |
| June 30, 2014 | -2.500M |
| March 31, 2014 | -3.069M |
| December 31, 2013 | -2.966M |
| September 30, 2013 | -2.486M |
| June 30, 2013 | -2.14M |
| March 31, 2013 | -2.266M |
| December 31, 2012 | -3.605M |
| September 30, 2012 | -4.617M |
| June 30, 2012 | -4.340M |
| March 31, 2012 | -3.065M |
| December 31, 2011 | -6.545M |
| September 30, 2011 | -6.797M |
| June 30, 2011 | -4.333M |
| March 31, 2011 | -3.955M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| CureVac NV | 319.28M |
| PAION AG | -- |
| Anbio Biotechnology | -- |
| Anika Therapeutics, Inc. | 3.309M |
| Perspective Therapeutics, Inc. | -26.98M |
Net Income (Quarterly) Related Metrics
| Enterprise Value | -2.521M |
| Earnings Yield | -27.75% |
| Normalized Earnings Yield | -27.26 |